Scholar Rock
IPO
Discovery and Development of Innovative Medicines
- Headquarters
- Cambridge, Massachusetts
- Employees
- 51–200
- Founded
- 2012
- Business Model
- B2B
- Website
- scholarrock.com
- Total Funding
- $103.0M
- Last Round
- $47.0M Series CJan 2018
About
Scholar Rock is a clinical-stage biopharmaceutical company founded on pioneering science from Harvard Medical School and Boston Children's Hospital. The company focuses on selectively targeting growth factor proteins in the TGF-beta superfamily before activation, with a pipeline spanning neuromuscular disorders, cardiometabolic conditions, immuno-oncology, fibrotic diseases, and hematology. Scholar Rock has been publicly traded on NASDAQ (SRRK) since 2018.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Sign up to view funding details
Create a free account to see full funding history, valuations, and investor participation.
Create Free Account